US Patent 9200008 Heterocyclic compound and p27
Patent 9200008 was granted and assigned to ASKA Pharmaceutical on December, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+214 characters)
Article
Patent abstract
A novel heterocyclic compound or a salt thereof useful for selectively inhibiting the degradation of p27Kip1 is provided. The compound or the salt thereof is represented by the following formula (1):
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09200008 Heterocyclic compound and p27 US Patent 9200008 Heterocyclic compound and p27
Infobox
Patent Number
0920000800
Patent Number
920000800
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
092000080
Date of Patent
December 1, 2015
0Patent Application Number
137018960
Date Filed
July 1, 2011
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
092000080
Date of Patent
December 1, 2015
0Patent Application Number
137018960
Date Filed
July 1, 2011
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09200008 Heterocyclic compound and p27
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09200008
Date of patent
December 1, 2015
Patent application number
13701896
Date Filed
July 1, 2011
Patent primary examiner
Find more entities like US Patent 9200008 Heterocyclic compound and p27
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.